Anti-Fibrinolytic Drugs

Revenue in the Anti-Fibrinolytics Drugs segment is projected to reach US$15,451m in 2021.
Revenue is expected to show an annual growth rate (CAGR 2021-2026) of 4.83%, resulting in a market volume of US$19,562m by 2026.

Contact

Get in touch with us. We are happy to help.

Hadley Ward

Sales Manager– Contact (United States)

Tel

Mon - Fri, 9am - 6pm (EST)

Ziyan Zhang

Customer Relations– Contact (Asia)

Tel

Mon - Fri, 11:30am - 10pm (IST)

Kisara Mizuno

Customer Success Manager– Contact (Asia)

Tel

Mon - Fri, 9:30am - 5:30pm (JST)

Lodovica Biagi

Director of Operations– Contact (Europe)

Tel

Mon - Fri, 9:30am - 5pm (GMT)

Catalina Rodriguez

Key Account Manager - LAC– Contact (Latin America)

Tel

Mon - Fri, 9am - 6pm (EST)